The cytosolic splicing variant of NELL2 inhibits PKC beta 1 in glial cells
- Authors
- Lee, Da Yong; Kim, Eunju; Lee, Young-Sun; Ryu, Hwani; Park, Jae-Yong; Hwang, Eun Mi
- Issue Date
- 21-11월-2014
- Publisher
- ACADEMIC PRESS INC ELSEVIER SCIENCE
- Keywords
- NELL2; Cytosolic NELL2; PKC beta 1; Astrocytes; Pseudosubstrate domain
- Citation
- BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, v.454, no.3, pp.459 - 464
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Volume
- 454
- Number
- 3
- Start Page
- 459
- End Page
- 464
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/96745
- DOI
- 10.1016/j.bbrc.2014.10.110
- ISSN
- 0006-291X
- Abstract
- NELL2 is an abundant glycoprotein containing EGF-like domain in the neural tissues where it has multiple physiological functions by interacting with protein kinase C (PKC). There are two different splicing variant forms of NELL2 identified so far. One is secreted NELL2 (sNELL2) which is a neuron-specific variant and the other is cytosolic NELL2 (cNELL2) which is non-secreted splicing variant of NELL2. Although cNELL2 structure was well characterized, the expression pattern or the cellular function of cNELL2 is not fully determined. In this study, we found that cNELL2 specifically interacts with PKC beta isotypes and inhibits PKC beta 1 through direct binding to the N-terminal pseudosubstrate domain of PKC beta 1. Here, we also demonstrate that cNELL2 is predominantly expressed and has inhibitory effects on the PKC downstream signaling pathways in astrocytes thereby establishing cNELL2 as an endogenous inhibitor of PKCB1 in glia. (C) 2014 Elsevier Inc. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Health Sciences > School of Biosystems and Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.